Skip to main content
OpenTrials
Completed

NCT Number: NCT03975218

Involvement of the Physician in Primary Prevention and Pre-hospital Management of Stroke

Stroke is a growing disease. It is the first pathology responsible for acquired handicap, the second of dementia and the second cause of death in the world. In France, they are the leading cause of death in women and the third cause in men. Sequelae and disabilities also represent a significant financial cost for health insurance.

The early management of the treatment improves the patient's vital and functional prognosis. The ability of the patient to identify the signs of stroke requiring urgent consultation and proper orientation are therefore crucial for further management.

The most common signs that patients must recognize are muscle weakness or sudden paralysis of an arm, leg or half of the body, asymmetry of the face, tingling, numbness of a hemi-body, speech or understanding, loss of vision of an eye or hemifield, disorder of the coordination of a hemi-body. The variety of clinical pictures complicates primary prevention.

In this context, a 2010-2014 National Stroke Action Plan was undertaken with the aim, among other things, of developing information to prevent stroke and to limit its sequelae. In this plan, the attending physician must improve prevention in high-risk patients and be a link between the city and the hospital for follow-up.

Several questions arise:

* Are patients who are regularly followed by a general practitioner better educated on the signs of stroke / TIA and thus more able to give an appropriate warning? * What is the profile of patients who have not been affected by the different modes of primary prevention? * What are the effective means of information and those desired

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Groupe Hospitalier Paris Saint-Joseph

Paris, 75014, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient whose age is ≥ 18 years
  • Patient hospitalized in the neurology / neurovascular department within the GHPSJ following a stroke (first episode or recurrence)
  • Francophone patient

Exclusion criteria

  • Patient with previously labeled cognitive impairment
  • Patient under tutorship or curatorship
  • Patient deprived of liberty
  • Patient unable to answer the questionnaire
  • Patient opposing participation in the study

Treatment and study plan

Patients With Stroke

Other

In addition to the usual care, the patient will have to complete a questionnaire analyzing the regularity of his follow-up by a physician.

Primary outcomes

  1. Time until patient's care in the hospital after stroke's symptoms

    Time frame: Day 1

    The delay between the observation of signs of stroke and specialized neurovascular management at the hospital will be measured. This measures the impact of physician's prevention on the management of stroke.

Secondary outcomes

  1. Study the different effective means of primary prevention

    Time frame: Day 1

    Patient questionnaire corresponds to open question about physician in primary prevention and pre-hospital management of stroke to which the patient will respond yes or no.

Sponsors and collaborators

Lead sponsor

Fondation Hôpital Saint-Joseph

Other

Registry information

Acronym: PREVENTION AVC

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Jun 5, 2019
Registry last updated
Dec 6, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.